The American Academy of Pediatrics (AAP) supports the Centers for Disease Control and Prevention’s (CDC’s) interim recommendation that quadrivalent live attenuated influenza vaccine (LAIV4) not be used in any setting during the 2016-’17 season.
Vaccination remains the best preventive measure against influenza, so everyone 6 months and older should receive any age-appropriate trivalent or quadrivalent (no preference) inactivated influenza vaccine (IIV) as soon as available.
Read the AAP cover story written by Henry Bernstein, DO, MHCM, FAAP, and David Kimberlin, M.D., FAAP, on pages 1 and 4 here.